Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.14 - $0.24 $847 - $1,452
-6,050 Reduced 13.31%
39,405 $8,000
Q1 2023

May 15, 2023

BUY
$0.16 - $0.74 $114 - $530
717 Added 1.6%
45,455 $7,000
Q4 2022

Feb 14, 2023

BUY
$0.46 - $1.21 $9,406 - $24,743
20,449 Added 84.19%
44,738 $25,000
Q3 2022

Nov 14, 2022

SELL
$0.59 - $1.7 $70,097 - $201,975
-118,809 Reduced 83.03%
24,289 $29,000
Q2 2022

Aug 15, 2022

SELL
$0.49 - $1.2 $126,507 - $309,814
-258,179 Reduced 64.34%
143,098 $90,000
Q1 2022

May 16, 2022

SELL
$0.85 - $2.4 $108,029 - $305,023
-127,093 Reduced 24.05%
401,277 $457,000
Q4 2021

Feb 14, 2022

SELL
$1.86 - $3.36 $1.8 Million - $3.26 Million
-969,422 Reduced 64.72%
528,370 $1.19 Million
Q3 2021

Nov 15, 2021

BUY
$1.52 - $3.82 $339,759 - $853,869
223,526 Added 17.54%
1,497,792 $5.12 Million
Q2 2021

Aug 16, 2021

BUY
$2.66 - $3.47 $629,449 - $821,123
236,635 Added 22.81%
1,274,266 $3.81 Million
Q1 2021

May 17, 2021

BUY
$1.98 - $5.36 $1.17 Million - $3.17 Million
591,482 Added 132.57%
1,037,631 $3.35 Million
Q4 2020

Feb 16, 2021

BUY
$1.05 - $2.77 $468,456 - $1.24 Million
446,149 New
446,149 $946,000
Q3 2020

Nov 16, 2020

SELL
$0.82 - $1.34 $11,193 - $18,292
-13,651 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$0.77 - $1.13 $3,542 - $5,197
-4,600 Reduced 25.2%
13,651 $12,000
Q1 2020

May 15, 2020

SELL
$0.69 - $1.52 $6,485 - $14,288
-9,400 Reduced 34.0%
18,251 $15,000
Q4 2019

Feb 14, 2020

SELL
$0.88 - $1.29 $5,896 - $8,643
-6,700 Reduced 19.5%
27,651 $27,000
Q3 2019

Nov 14, 2019

SELL
$1.03 - $1.75 $4,219 - $7,169
-4,097 Reduced 10.66%
34,351 $35,000
Q2 2019

Aug 14, 2019

SELL
$1.43 - $1.87 $5,900 - $7,715
-4,126 Reduced 9.69%
38,448 $69,000
Q1 2019

May 15, 2019

SELL
$1.18 - $1.91 $57,491 - $93,059
-48,722 Reduced 53.37%
42,574 $80,000
Q4 2018

Feb 14, 2019

BUY
$1.01 - $2.78 $20,928 - $57,604
20,721 Added 29.36%
91,296 $108,000
Q3 2018

Nov 14, 2018

BUY
$1.72 - $2.71 $121,389 - $191,258
70,575 New
70,575 $191,000

Others Institutions Holding INFI

About INFINITY PHARMACEUTICALS, INC.


  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.